Use of lumefantrine and related compounds in the treatment of cancer
OwnerDouglas Tyler McKenzieinventor
Life of this patent
Estimating the term…
Abstract
The present application discloses the use of the anti-malarial drug lumefantrine and related compounds in the treatment of cancer.
Claims24
A method of treating cancer, comprising administration of lumefantrine or desbutyl-lumefantrine to a patient in need thereof.
A pharmaceutical composition comprising lumefantrine and an ER stressor drug.
A pharmaceutical composition comprising desbutyl-lumefantrine and an ER stressor drug.
A method of treating cancer, comprising administration of a drug selected from the group consisting of amodiaquine, mefloquine, naphthoquine, pamaquine, primaquine, piperaquine, tafenoquine, quinacrine, mepacrine, halofantrine, pyronaridine, nitazoxanide, and atovaquone (alternative spelling:
- atavaquone) to a patient in need thereof.
A pharmaceutical composition comprising an ER stressor drug and a drug selected from the group consisting of amodiaquine, mefloquine, naphthoquine, pamaquine, primaquine, piperaquine, tafenoquine, quinacrine, mepacrine, halofantrine, pyronaridine, nitazoxanide, and atovaquone (alternative spelling:
- atavaquone).
Dependencies are inferred from the claim text.